These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 14999228

  • 1. Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity.
    Richardson TB, Kaspers J, Porter CD.
    Gene Ther; 2004 May; 11(9):775-83. PubMed ID: 14999228
    [Abstract] [Full Text] [Related]

  • 2. Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.
    Mavria G, Jäger U, Porter CD.
    Gene Ther; 2000 Mar; 7(5):368-76. PubMed ID: 10694818
    [Abstract] [Full Text] [Related]

  • 3. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
    Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R.
    Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy.
    Ingram N, Porter CD.
    Gene Ther; 2005 Jul; 12(13):1058-69. PubMed ID: 15800661
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences.
    Jäger U, Zhao Y, Porter CD.
    J Virol; 1999 Dec; 73(12):9702-9. PubMed ID: 10559279
    [Abstract] [Full Text] [Related]

  • 7. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
    Brandtner EM, Kodajova P, Hlavaty J, Jandl G, Tabotta W, Salmons B, Günzburg WH, Hohenadl C.
    J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
    [Abstract] [Full Text] [Related]

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 9. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D, Elliott JF, Chang LJ.
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
    Ohnishi N, Itoh K, Itoh Y, Baum C, Higashitsuji H, Yamaguchi K, Tsuji T, Okanoue T, Fujita J.
    Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
    Tabotta W, Klein D, Hohenadl C, Salmons B, Günzburg WH.
    J Gene Med; 2001 Feb; 3(5):418-26. PubMed ID: 11601755
    [Abstract] [Full Text] [Related]

  • 16. Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
    Modlich U, Pugh CW, Bicknell R.
    Gene Ther; 2000 May; 7(10):896-902. PubMed ID: 10845728
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Retroviral vector sequences may interact with some internal promoters and influence expression.
    Wu X, Holschen J, Kennedy SC, Ponder KP.
    Hum Gene Ther; 1996 Jan 20; 7(2):159-71. PubMed ID: 8788167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
    Yoshimura FK, Wang T.
    Virology; 2001 Apr 25; 283(1):121-31. PubMed ID: 11312668
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.